PREFERRED PHARMACEUTICAL FORMULATIONS BY PATIENTS SUFFERING FROM SEXUAL DYSFUNCTION VISITING PSYCHIATRY OUT PATIENT DEPARTMENT IN AN TERTIARY CARE CENTER
Keywords:sexual dysfunction, pharmaceutical formulation, ayurvedic, allopathy
Objective: Sexual dysfunctions are increasing day by day. Various formulations are available for the treatment of same. There has been psychological mind-set among Indian patients to have powdered medicines for the sexual dysfunction management. The aim of this study was to analyze the preferred formulation by the patients for the treatment sexual dysfunction.
Methods: A cross-sectional and observational study was undertaken from January 2018–January 2019 in psychiatry OPD of a tertiary care teaching institute after approval from the Institutional Ethics Committee. A semi-structured questionnaire was made collecting information on demographic details and preferred pharmaceutical formulations for the treatment of sexual dysfunctions.
Results: Out of 164 participants who were analyzed, the most common age group having sexual dysfunctions was found to be 21–30 years (44%). Patients preferred Ayurvedic form of treatment (38.41%) over Allopathic (23.17%). Patients were in favor of SOS medications (51.83%) than day or night doses. Majority of the patients wanted drugs in tablet form (67.07%), in monthly doses (43.9%), of white color (39.02%), along with water (54.88%) and at <Rs.100 per strip (67.07%).
Conclusions: Majority of the patients prefer Ayurvedic form of treatment and SOS, on monthly basis, white colored tablets, taken with water at affordable prices. These factors need to be kept in mind while formulating new drugs and guidelines to ensure better compliance.
Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, et al. Sexual problems among women and men aged 40-80 y: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005;17:39-57. doi: 10.1038/sj.ijir.3901250, PMID 15215881
Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999;84:50-6. doi: 10.1046/j.1464- 410x.1999.00142.x, PMID 10444124
Rosen RC. Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep 2000;2:189-95. doi: 10.1007/s11920- 996-0006-2, PMID 11122954
Hackett GI. Patient preference in treatment of erectile dysfunction: The continuing importance of patient education. Clin Cornerstone 2005;7:57-65. doi: 10.1016/s1098-3597(05)80049-3, PMID 16156424
Sample Size Calculator-Confidence Level, Confidence Interval, Sample Size, Population Size, Relevant Population. Creative Research Systems. Available from: https://www.surveysystem.com/sscalc.htm
Verma R, Mina S, Ul-Hassan S, Balhara YP. A descriptive analysis of patients presenting to psychosexual clinic at a tertiary care center. Indian J Psychol Med 2013;35:241-7. doi: 10.4103/0253-7176.119473, PMID 24249924
Gupta SK, Dayal S, Jain VK, Kataria U, Relhan V. Profile of male patients presenting with psychosexual disorders. Indian J Sex Trans Dis 2004;25:33-7.
Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2004;172:658-63. doi: 10.1097/01. ju.0000132389.97804.d7, PMID 15247755
Chauhan NS, Sharma V, Dixit VK, Thakur M. A review on plants used for improvement of sexual performance and virility. BioMed Res Int 2014;2014:868062. doi: 10.1155/2014/868062, PMID 25215296
Baldi A. Erectile dysfunction and ayurveda. J Res Educ Indian Med 2009;32:15-24.
Huang SA, Lie JD. Phosphodiesterase-5 (PDE-5) inhibitors in the management of erectile dysfunction. Pharm Ther 2013;38:407, 414-9.
How to Cite
Copyright (c) 2022 Neha Shende, Sharmada Nerlekar, Abhilasha Rashmi, sagar karia, Sudhir Pawar
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.